Streetbeat News

Stock Prices

SIX

B. Riley Securities analyst Eric Wold upgraded Six Flags Entertainment (NYSE:SIX) from Neutral to Buy and increased the price target from $30 to $31.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 5:10 pm

EXPE

Wedbush analyst Scott Devitt reiterates a Neutral rating on Expedia Group (EXPE) and maintains a $130 price target.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 5:08 pm

BNTC

Benitec Biopharma Inc (NASDAQ:BNTC) reported positive interim clinical data from its BB-301 Phase 1b/2a study in Oculopharyngeal Muscular Dystrophy (OPMD), showing improvements in swallowing functions without severe side effects. Additionally, the company announced a $40 million PIPE financing, leading to a 24% increase in its stock price.

Portfolio Pulse from Vandana Singh

April 18, 2024 | 5:04 pm

FVRR

Fiverr Intl (NYSE:FVRR) has been the subject of diverse analyst evaluations over the last three months, with ratings ranging from bullish to bearish. The average 12-month price target for FVRR is now $31.75, down from $33.67, reflecting a 5.7% decrease. Analysts from firms like BTIG, JP Morgan, and Citigroup have adjusted their price targets and ratings, indicating a cautious outlook on the company's performance. Despite this, Fiverr's financial performance shows strong revenue growth and net margin, but challenges in ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:02 pm

BIO

CCL

CZR

GL

SPY

WBD

XLE

XLRE

96% of S&P 500 companies are trading below Wall Street targets, indicating potential profits. SPDR S&P 500 ETF Trust (SPY) fell 3.7% in April, the worst month since September 2023. Only the Energy Select Sector SPDR Fund (XLE) avoided losses, while the Real Estate Select Sector SPDR Fund (XLRE) dropped 10%. High inflation and geopolitical risks have increased market volatility, presenting buying opportunities. Top contrarian stocks include Globe Life (GL), Caesars Entertainment (CZR), Warner Bros. Discovery (WBD), Bio-Rad Laboratories (BIO), and Carnival Corp (CCL), all showing significant gaps between current prices and analyst targets.

Portfolio Pulse from Piero Cingari

April 18, 2024 | 5:01 pm

REG

Four analysts have recently published ratings on Regency Centers (NASDAQ:REG), showing a mix of bullish to indifferent sentiments. The average 12-month price target is now $68.25, a decrease from the previous $72.00. Analyst actions include adjustments to ratings and price targets, reflecting changes in market conditions and company performance. Regency Centers, a leading retail REIT, reported a revenue growth of 14.34% and faces challenges in profitability and asset utilization, with a net margin of 24.02% and ROA of 0.7%.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:01 pm

HON

Over the past 20 years, Honeywell Intl (NASDAQ:HON) has produced an average annual return of 9.05%, outperforming the market. A $1000 investment in HON 20 years ago would now be worth $5,765.51. Honeywell currently has a market capitalization of $124.24 billion.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:00 pm

CRI

Carter's (NYSE:CRI) has been the subject of varied analyst ratings over the past three months, with a recent shift towards a more bearish outlook. Despite this, the average 12-month price target for CRI has increased to $73.4, up from $67.80. Analysts from Citigroup, UBS, Evercore ISI Group, and Wedbush have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Carter's faces revenue challenges with a -5.95% decline over 3 months but maintains strong profitability indicators such as a net margin of 12.18% and ROE of 12.82%.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:00 pm

ACN

Over the past 20 years, Accenture (NYSE:ACN) has delivered an average annual return of 13.71%, outperforming the market by 6.03% on an annualized basis. A $1000 investment in ACN 20 years ago would be worth $12,991.18 today, showcasing the impact of compounded returns over time. Accenture's current market capitalization stands at $199.22 billion.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:00 pm

MDT

Medtronic's (NYSE:MDT) short interest has increased by 8.05% since the last report, with 12.43 million shares sold short, representing 0.94% of its float. This indicates a bearish market sentiment, although it's lower than its peers' average of 4.21%. The coverage time for these short positions is approximately 2.18 days based on current trading volumes.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:00 pm